Form 4: Bio-Key International Director Acquires Shares Through Stock Incentive Plan

Director Emmanuel Alia acquired 3,500 shares of Bio-Key International common stock on July 31, 2024, through the company's 2023 Stock Incentive Plan.

Summary

• On July 31, 2024, Emmanuel Alia, a director of Bio-Key International, acquired 3,500 shares of common stock.
• The acquisition was made through the Issuer's 2023 Stock Incentive Plan.
• The shares were granted as restricted stock and will vest in three equal annual installments, contingent upon continued service to the Issuer.
• Following the transaction, Alia directly owns 6,868 shares of Bio-Key International.
• Alia also holds options to purchase 18 shares, which are not included in the reported holdings.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. A director acquiring shares through a stock incentive plan is generally a good sign, indicating confidence in the company's future. However, it's a routine transaction and doesn't provide significant new information.

Positives

• The acquisition of shares by a director signals confidence in the company's future.
• The vesting schedule of the restricted stock incentivizes continued service and alignment with company goals.

Future Outlook

The vesting of the restricted stock is contingent upon the Reporting Person's continued employment with or service to the Issuer through the applicable vesting date.

Industry Context

This Form 4 filing is a routine disclosure related to insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company insiders and their alignment with shareholder interests.

Stakeholder Impact

• The acquisition of shares by a director can positively influence shareholder sentiment.

Key Dates

Keywords

Bio-Key International, Director, Stock Incentive Plan, Share Acquisition, Form 4, BKYI, Restricted Stock, Beneficial Ownership